Cyclacel Pharmaceuticals Share Price (NASDAQ: CYCC)
$8.29
▲
0.47
(6.01%)
Last updated on
Check the interactive Cyclacel Pharmaceuticals Stock chart to analyse performance
Cyclacel Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$7.84Today's High:$8.68
5.43%
Downside
Day's Volatility :9.68%
Upside
4.49%
- 52 Weeks Low:$3.0852 Weeks High:$597.60
62.85%
Downside
52 Weeks Volatility :99.48%
Upside
98.61%
Cyclacel Pharmaceuticals Stock Returns
Cyclacel Pharmaceuticals Inc Key Stats
Check Cyclacel Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Cyclacel Pharmaceuticals Stock including INR - Dollar returns
The Cyclacel Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cyclacel Pharmaceuticals investment value today
Current value as on today
₹8,568
Returns
Returns from Cyclacel Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Cyclacel Pharmaceuticals Stock
Global Institutional Holdings in Cyclacel Pharmaceuticals Inc
Name
Holdings %
Analyst Recommendation on Cyclacel Pharmaceuticals Stock
Buy
77%Buy
22%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Cyclacel Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Cyclacel Pharmaceuticals Share Price Target
What analysts predicted
Downside of 87.94%
Target:
$1.00
Current:
$8.29
Cyclacel Pharmaceuticals share price target is $1.00, a slight Downside of 87.94% compared to current price of $8.29 as per analysts' prediction.
Cyclacel Pharmaceuticals Stock Insights
Price Movement
In the last 1 month, CYCC stock has moved down by -33.0%CYCC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 166.6%CYCC vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.5%Price to Sales
ForCYCC every $1 of sales, investors are willing to pay $1383.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Cyclacel Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Cyclacel Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Cyclacel Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -25.96% | -89.27% | -96.71% | -99.86% | -99.94% |
 | 6.48% | -15.2% | -50.98% | -0.05% | -6.32% |
 | 1.77% | 24.81% | 59.79% | 78.52% | 26.86% |
 | -14.45% | -19.13% | -21.18% | 38.72% | 40.03% |
 | 13.79% | 83.28% | 69.91% | 115.96% | 236.5% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.0 | 0.0 | 0.0 | 0.0 | -2.77 | -1.03 | 0.0 | 2.29 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $17.5M | -99.94% | 0.0 | 0.0% |
| Buy | $61.4B | -6.32% | 14.6 | 31.37% |
| NA | $36.5B | 26.86% | NA | -3.89% |
| Buy | $100.5B | 40.03% | 27.86 | 31.86% |
| Buy | $59.5B | 236.5% | NA | -12.96% |
About Cyclacel Pharmaceuticals Inc
Key Management of Cyclacel Pharmaceuticals Inc
Important FAQs about investing in CYCC Stock from India :
What is Cyclacel Pharmaceuticals share price today?
Cyclacel Pharmaceuticals share price today is $8.29 as on at the close of the market. Cyclacel Pharmaceuticals share today touched a day high of $8.68 and a low of $7.84.
What is the 52 week high and 52 week low for Cyclacel Pharmaceuticals share?
Cyclacel Pharmaceuticals share touched a 52 week high of $597.60 and a 52 week low of $3.08. Cyclacel Pharmaceuticals stock price today i.e. is closed at $8.29, lower by 98.61% versus the 52 week high.
How to invest in Cyclacel Pharmaceuticals Stock (CYCC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cyclacel Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cyclacel Pharmaceuticals Shares that will get you 0.1809 shares as per Cyclacel Pharmaceuticals share price of $8.29 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Cyclacel Pharmaceuticals Stock (CYCC) from India?
Indian investors can start investing in Cyclacel Pharmaceuticals (CYCC) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cyclacel Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 30, 2025).
Based on Cyclacel Pharmaceuticals share’s latest price of $8.29 as on August 30, 2025 at 1:29 am IST, you will get 1.2063 shares of Cyclacel Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Cyclacel Pharmaceuticals has given to Indian investors in the last 5 years?
Cyclacel Pharmaceuticals stock has given -99.94% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%